Trial Profile
Basket of Baskets: A Modular, Open-label, Phase II, Multicentre Study To Evaluate Targeted Agents in Molecularly Selected Populations With Advanced Solid Tumors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2023
Price :
$35
*
At a glance
- Drugs Amivantamab (Primary) ; Atezolizumab (Primary) ; Futibatinib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Acronyms BoB
- 09 Jun 2023 Number of treatment arms increased from 1 to 3 by the addition of Experimental: Module 2 - Futibatinib and Experimental: Module 3 - Amivantamab arms, thus adding 1 more study drugs. Janssen is added as a collaborator.
- 11 Oct 2022 Planned End Date changed from 1 Nov 2022 to 1 Nov 2026.
- 11 Oct 2022 Planned primary completion date changed from 1 May 2022 to 1 May 2025.